Literature DB >> 28316879

A Preliminary Study of Genetic Variation in the Dopaminergic and Serotonergic Systems and Genome-wide Additive Genetic Effects on Depression Severity and Treatment Response.

Rohan H C Palmer1, Christopher G Beevers2, John E McGeary3, Leslie A Brick4, Valerie S Knopik1.   

Abstract

Entities:  

Keywords:  Clinical trials; Depression; Genetics

Year:  2016        PMID： 28316879      PMCID： PMC5353843          DOI： 10.1177/2167702616651075

Source DB:  PubMed          Journal:  Clin Psychol Sci        ISSN： 2167-7034


× No keyword cloud information.
  38 in total

Review 1.  The costs of depression.

Authors:  Ronald C Kessler
Journal:  Psychiatr Clin North Am       Date:  2011-12-16

2.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

3.  Severity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement.

Authors:  Ronald C Kessler; Shelli Avenevoli; Jane Costello; Jennifer Greif Green; Michael J Gruber; Katie A McLaughlin; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Kathleen Ries Merikangas
Journal:  Arch Gen Psychiatry       Date:  2012-04

4.  Evolution and functional impact of rare coding variation from deep sequencing of human exomes.

Authors:  Jacob A Tennessen; Abigail W Bigham; Timothy D O'Connor; Wenqing Fu; Eimear E Kenny; Simon Gravel; Sean McGee; Ron Do; Xiaoming Liu; Goo Jun; Hyun Min Kang; Daniel Jordan; Suzanne M Leal; Stacey Gabriel; Mark J Rieder; Goncalo Abecasis; David Altshuler; Deborah A Nickerson; Eric Boerwinkle; Shamil Sunyaev; Carlos D Bustamante; Michael J Bamshad; Joshua M Akey
Journal:  Science       Date:  2012-05-17       Impact factor: 47.728

Review 5.  Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies.

Authors:  H G Ruhé; N S Mason; A H Schene
Journal:  Mol Psychiatry       Date:  2007-01-16       Impact factor: 15.992

6.  Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons.

Authors:  Miriam Melis; Simona Perra; Anna Lisa Muntoni; Giuliano Pillolla; Beat Lutz; Giovanni Marsicano; Vincenzo Di Marzo; Gian Luigi Gessa; Marco Pistis
Journal:  J Neurosci       Date:  2004-11-24       Impact factor: 6.167

Review 7.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

8.  Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

Authors:  A John Rush; Maurizio Fava; Stephen R Wisniewski; Philip W Lavori; Madhukar H Trivedi; Harold A Sackeim; Michael E Thase; Andrew A Nierenberg; Frederic M Quitkin; T Michael Kashner; David J Kupfer; Jerrold F Rosenbaum; Jonathan Alpert; Jonathan W Stewart; Patrick J McGrath; Melanie M Biggs; Kathy Shores-Wilson; Barry D Lebowitz; Louise Ritz; George Niederehe
Journal:  Control Clin Trials       Date:  2004-02

Review 9.  The genetics of major depression.

Authors:  Jonathan Flint; Kenneth S Kendler
Journal:  Neuron       Date:  2014-02-05       Impact factor: 17.173

10.  A genome-wide association study of a sustained pattern of antidepressant response.

Authors:  Aimee M Hunter; Andrew F Leuchter; Robert A Power; Bengt Muthén; Patrick J McGrath; Cathryn M Lewis; Ian A Cook; Holly A Garriock; Peter McGuffin; Rudolf Uher; Steven P Hamilton
Journal:  J Psychiatr Res       Date:  2013-05-30       Impact factor: 4.791
View more
  1 in total

1.  Inclusion of genetic variants in an ensemble of gradient boosting decision trees does not improve the prediction of citalopram treatment response.

Authors:  Jason Shumake; Travis T Mallard; John E McGeary; Christopher G Beevers
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.